- In July 2022, Incyte’s Opzelura (Ruxolitinib) Cream received approval from the U.S. FDA for the treatment of vitiligo, making it the first and only FDA-approved repigmentation therapy for nonsegmental vitiligo
- In February 2022, STRATA Skin Sciences, Inc., a medical technology company specializing in dermatologic treatments, announced the commercial launch of its next-generation excimer laser system, XTRAC Momentum 1.0, with its first installation in the U.S
- In January 2022, STRATA Skin Sciences, Inc. introduced its XTRAC Momentum 1.0 excimer laser system, expanding its portfolio of advanced dermatology solutions with the system’s first installation in the U.S
- In October 2021, The Uniza Group launched Vitellus, an innovative vitiligo management solution featuring a combination of Greyverse, Melitane, GL 200, and EUK-134. This three-in-one formulation supports melanin production, skin and hair follicle pigmentation, and provides antioxidant benefits
- In October 2021, The Uniza Group announced the introduction of Vitellus, an advanced vitiligo treatment designed to stimulate pigmentation and improve skin health using cutting-edge ingredients
